DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

107.94 3.69 (3.54%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MDVN $107.94 3.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $105.30
Previous Close $104.25
Daily Range $103.97 - $108.06
52-Week Range $54.37 - $117.23
Market Cap $8.4B
P/E Ratio 73.42
Dividend (Yield) $0.00 (0.0%)
Volume 936,753
Average Daily Volume 1,091,980
Current FY EPS $2.58





Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website:

News & Commentary Rss Feed

Johnson & Johnson Overcomes Threats from Competitors, Delivers Solid Quarterly Results

Revenue and earnings climbed during the fourth quarter on an operational basis.

First Week of September 18th Options Trading For Medivation (MDVN)

Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation Brands Inc, and ...

Medivation and Astellas Report TERRAIN Data on Xtandi - Analyst Blog

Medivation's Xtandi Easily Outperforms Casodex In Key Trial

Thursday's ETF with Unusual Volume: MTUM

MDVN March 6th Options Begin Trading

Medivation (MDVN) Weak On High Volume Today

Johnson & Johnson Finding Growth A Little Harder Now

Why Medivation Inc. Stock Sank 14% in December

Medivation shares plunge in December on fears of a price war breaking out between cancer drug developers. Find out if this dip is worth buying.

See More MDVN News...

MDVN's Top Competitors

MDVN $107.94 (3.54%)
Current stock: MDVN
TMO $127.96 (2.91%)
Current stock: TMO
ILMN $200.00 (1.08%)
Current stock: ILMN
WAT $120.62 (1.40%)
Current stock: WAT